Viatris Valuation
VTRS Stock | USD 9.10 0.12 1.34% |
At this time, the company appears to be undervalued. Viatris has a current Real Value of $10.41 per share. The regular price of the company is $9.1. Our model measures the value of Viatris from inspecting the company fundamentals such as Shares Outstanding of 1.19 B, return on equity of -0.0324, and Operating Margin of 0.13 % as well as reviewing its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Viatris' price fluctuation is not too volatile at this time. Calculation of the real value of Viatris is based on 3 months time horizon. Increasing Viatris' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Viatris stock is determined by what a typical buyer is willing to pay for full or partial control of Viatris. Since Viatris is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Viatris Stock. However, Viatris' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 9.1 | Real 10.41 | Hype 9.16 | Naive 9.07 |
The intrinsic value of Viatris' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Viatris' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Viatris helps investors to forecast how Viatris stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Viatris more accurately as focusing exclusively on Viatris' fundamentals will not take into account other important factors: Viatris Total Value Analysis
Viatris is at this time projected to have valuation of 24.06 B with market capitalization of 10.86 B, debt of 15.99 B, and cash on hands of 741.9 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Viatris fundamentals before making equity appraisal based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
24.06 B | 10.86 B | 15.99 B | 741.9 M |
Viatris Investor Information
About 86.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 0.58. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Viatris has Price/Earnings To Growth (PEG) ratio of 0.15. The entity recorded a loss per share of 0.53. The firm last dividend was issued on the 10th of March 2025. Viatris had 3:2 split on the 9th of October 2003. Based on the key indicators related to Viatris' liquidity, profitability, solvency, and operating efficiency, Viatris is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Viatris Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Viatris has an asset utilization ratio of 35.52 percent. This implies that the Company is making $0.36 for each dollar of assets. An increasing asset utilization means that Viatris is more efficient with each dollar of assets it utilizes for everyday operations.Viatris Ownership Allocation
Viatris shows a total of 1.19 Billion outstanding shares. The majority of Viatris outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Viatris to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Viatris. Please pay attention to any change in the institutional holdings of Viatris as this could imply that something significant has changed or is about to change at the company. On January 26, 2021, Representative Mo Brooks of US Congress acquired under $15k worth of Viatris's common stock.Viatris Profitability Analysis
The company reported the previous year's revenue of 14.74 B. Net Loss for the year was (634.2 M) with profit before overhead, payroll, taxes, and interest of 6.14 B.Viatris Past Distributions to stockholders
About Viatris Valuation
The stock valuation mechanism determines Viatris' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Viatris based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Viatris. We calculate exposure to Viatris's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Viatris's related companies.The company operates in four segments Developed Markets, Greater China, JANZ, and Emerging Markets. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania. Viatris operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 37000 people.
A single share of Viatris represents a small ownership stake in the entity. As a stockholder of Viatris, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Viatris Dividends Analysis For Valuation
There are various types of dividends Viatris can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Viatris shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Viatris directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Viatris pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Viatris by the value of the dividends paid out.
Viatris Growth Indicators
Investing in growth stocks can be very risky. If the company such as Viatris does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding | 1.2 B | |
Quarterly Earnings Growth Y O Y | -0.706 | |
Forward Price Earnings | 4.2373 |
Additional Tools for Viatris Stock Analysis
When running Viatris' price analysis, check to measure Viatris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viatris is operating at the current time. Most of Viatris' value examination focuses on studying past and present price action to predict the probability of Viatris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viatris' price. Additionally, you may evaluate how the addition of Viatris to your portfolios can decrease your overall portfolio volatility.